Pharmacogenetic Drug Trials: Genetic Test Availability Will Determine Scope
Executive Summary
Drugs that are more effective in populations defined through pharmacogenetic studies may need testing in broader populations as well, depending on whether screening is available to identify the appropriate patients in clinical practice, FDA Medical Policy Director Robert Temple, MD, said